Gretalmed OÜ

Active Registry code 16525319 OÜ Raadi alev Registered 27 Jun 2022
Compare

Gretalmed OÜ is a OÜ based in Raadi alev, registry code 16525319, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €28 208 and 0 employees.

Revenue
28 208 €
↓ 11.7% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 28 208 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 66.2 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2022 – 2025
Revenue, € 2025: 28 208 € · −11.7% vs 2024 · industry median 0 € · above 81% of the industry
010 00020 00030 00040 0002022 Company: — Industry median: 103 €20222023 Company: 14 732 € Industry median: 76 €20232024 Company: 31 934 € Industry median: 0 €20242025 Company: 28 208 € Industry median: 0 €2025010 00020 00030 00040 0002022 Company: — Industry median: 103 €2023 Company: 14 732 € Industry median: 76 €20232024 Company: 31 934 € Industry median: 0 €2025 Company: 28 208 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 18 683 € · +20.7% vs 2024 · industry median 0 € · above 87% of the industry
05 00010 00015 00020 0002022 Company: 0 € Industry median: 0 €20222023 Company: 12 941 € Industry median: 0 €20232024 Company: 15 478 € Industry median: 0 €20242025 Company: 18 683 € Industry median: 0 €202505 00010 00015 00020 0002022 Company: 0 € Industry median: 0 €2023 Company: 12 941 € Industry median: 0 €20232024 Company: 15 478 € Industry median: 0 €2025 Company: 18 683 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 66.2 % · +17.8 pp vs the year before · industry median 13.5 % · above 81% of the industry
0204060801002022 Company: — Industry median: 17.7 %20222023 Company: 87.8 % Industry median: 16.8 %20232024 Company: 48.5 % Industry median: 15.8 %20242025 Company: 66.2 % Industry median: 13.5 %20250204060801002022 Company: — Industry median: 17.7 %2023 Company: 87.8 % Industry median: 16.8 %20232024 Company: 48.5 % Industry median: 15.8 %2025 Company: 66.2 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 51 365 € · +52.4% vs 2024
020 00040 00060 0002022 Company: —20222023 Company: 13 868 €20232024 Company: 33 703 €20242025 Company: 51 365 €2025020 00040 00060 0002022 Company: —2023 Company: 13 868 €20232024 Company: 33 703 €2025 Company: 51 365 €2025
Equity, € 2025: 47 102 € · +65.7% vs 2024
010 00020 00030 00040 00050 0002022 Company: —20222023 Company: 12 941 €20232024 Company: 28 419 €20242025 Company: 47 102 €2025010 00020 00030 00040 00050 0002022 Company: —2023 Company: 12 941 €20232024 Company: 28 419 €2025 Company: 47 102 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 28 208 18 683 0 51 365 47 102 0
2024 31 934 15 478 0 33 703 28 419 0
2023 14 732 12 941 0 13 868 12 941 0
2022 — 0 0 — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
66.2 %
Net profit / revenue
Return on equity (ROE)
39.7 %
Net profit / equity
Return on assets (ROA)
36.4 %
Net profit / assets
Equity ratio
91.7 %
Equity / assets
Debt ratio
8.3 %
Liabilities / assets
Current ratio
12.05
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 8 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 2 Jul 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 1 Jul 2024 Company’s own e-Äriregister
2022 27 Jun 2022 – 31 Dec 2022 30 Jun 2023 Company’s own e-Äriregister

Board

  • Eve Laane
    Board member · since 27 Jun 2022

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

  • Eve Laane
    Natural person · 2 500 €

Beneficial owners

  • Eve Laane
    Direct ownership · since 27 Jun 2022

Founders and other persons

  • Eve Laane
    Founder · 2 500 € · 15 Jun 2022

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 5

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50205080 / 3
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50205080 / 2
16 Aug 2022
 Amendment entry In force
16 Aug 2022
 PDF
Ä 50205080
27 Jun 2022
 First entry In force
27 Jun 2022
 PDF
Ä 50205080 / M2
17 Jun 2022
 Ruling to eliminate deficiencies 17 Jul 2022 Deficiencies eliminated
27 Jun 2022
 PDF
Ä 50205080 / M1
15 Jun 2022
 Ruling to eliminate deficiencies 15 Jul 2022 Deficiencies eliminated
27 Jun 2022
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data